Trials / Withdrawn
WithdrawnNCT02309632
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Arkansas · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
100 subjects who have a family history of pancreatic cancer (PC), or known genetic syndromes associated with increased risk of pancreatic cancer, will be followed for five years. This data will be used to determine the pancreatic cancer and precancerous lesion detection rate in High Risk Individuals (HRIs). Subjects may agree to annual imaging and annual biomarkers or to biomarkers only.
Conditions
- Pancreatic Neoplasms
- Peutz-Jegher's Syndrome
- BRCA1 Gene Mutation
- BRCA2 Gene Mutation
- Ataxia Telangiectasia
- Familial Atypical Mole-Malignant Melanoma Syndrome
- Colorectal Neoplasms, Hereditary Nonpolyposis
- Hereditary Pancreatitis
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pancreatic Cancer Screening Pathway 1 | Screening with imaging and biomarker testing |
| OTHER | Pancreatic Cancer Screening Pathway 2 | Screening with biomarker testing only |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2019-07-19
- Completion
- 2019-07-19
- First posted
- 2014-12-05
- Last updated
- 2019-07-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02309632. Inclusion in this directory is not an endorsement.